# Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation

> **NCT02827357** · — · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 101 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** No specific intervention

## Key facts

- **NCT ID:** NCT02827357
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02827357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02827357, "Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02827357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*